CRISPR Therapeutics (CRSP)
(Delayed Data from NSDQ)
$45.58 USD
-1.40 (-2.98%)
Updated Oct 1, 2024 04:00 PM ET
After-Market: $45.62 +0.04 (0.09%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth B Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/4/24 |
---|---|
Current Quarter | -1.45 |
EPS Last Quarter | -1.49 |
Last EPS Surprise | -8.76% |
ABR | 2.16 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -5.58 |
Next Year | -4.98 |
EPS (TTM) | -3.23 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 6.36M | 60.54M | 64.20M | 470.99M |
# of Estimates | 8 | 10 | 12 | 11 |
High Estimate | 12.60M | 455.70M | 458.90M | 3.31B |
Low Estimate | 0.74M | 0.74M | 1.02M | 70.33M |
Year ago Sales | 0.00M | 201.21M | 371.21M | 64.20M |
Year over Year Growth Est. | NA | -69.91% | -82.70% | 633.62% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -1.45 | -1.17 | -5.58 | -4.98 |
# of Estimates | 12 | 11 | 14 | 14 |
Most Recent Consensus | -1.18 | -1.57 | -6.13 | -5.88 |
High Estimate | -1.00 | -0.10 | -4.66 | 5.05 |
Low Estimate | -1.83 | -1.82 | -6.54 | -7.59 |
Year ago EPS | -1.41 | 1.10 | -1.94 | -5.58 |
Year over Year Growth Est. | -2.84% | -206.36% | -187.63% | 10.79% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 4 | 5 | 7 | 6 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 5 | 6 | 6 | 7 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -1.45 | -1.17 | -5.58 | -4.98 |
7 Days Ago | -1.45 | -1.17 | -5.58 | -4.98 |
30 Days Ago | -1.45 | -1.17 | -5.58 | -4.98 |
60 Days Ago | -1.33 | -1.19 | -5.66 | -4.45 |
90 Days Ago | -1.33 | -1.19 | -5.65 | -4.44 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -1.45 | -1.17 | -6.54 | -5.55 |
Zacks Consensus Estimate | -1.45 | -1.17 | -5.58 | -4.98 |
Earnings ESP | 0.00% | 0.00% | -17.27% | -11.56% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.49 | -1.43 | 1.10 | -1.41 | NA |
Estimate | -1.37 | -1.63 | -0.40 | -1.98 | NA |
Difference | -0.12 | 0.20 | 1.50 | 0.57 | 0.54 |
Surprise | -8.76% | 12.27% | 375.00% | 28.79% | 101.83% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more